Concepedia
Statistics
Publications
18
Citations
1.2K
H-Index
15
Active since
1965
Affiliations
Pfizer (United States)(Current)
Brandeis University
Paul Scherrer Institute
University of Connecticut
Aaron M. D’Antona is an author at Pfizer (United States) specializing in medicine, natural sciences, and antibody engineering.
Top concepts
MedicineNatural SciencesAntibody EngineeringBiochemistryProtein EngineeringSignal TransductionCellular BiochemistryCell BiologyMolecular BiologyBiomolecular Engineering
Publications per year
1965–2023
The structural basis of agonist-induced activation in constitutively active rhodopsin
Jörg Standfuss, Patricia C. Edwards, Aaron M. D’Antona et al. · Nature · 2011 · 464 citations · Full text
Molecular Pharmacology, Agonist-induced Activation, Signal Transduction +11
Oleamide is a selective endogenous agonist of rat and human CB<sub>1</sub> cannabinoid receptors
James D. Leggett, Sue Aspley, Simon Beckett et al. · British Journal of Pharmacology · 2004 · 172 citations · Full text
Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail
Helena Andersson, Aaron M. D’Antona, Debra A. Kendall et al. · Molecular Pharmacology · 2003 · 123 citations
Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer
Adam Root, Wei Cao, Bilian Li et al. · Antibodies · 2016 · 92 citations · Full text
Mutations of CB<sub>1</sub> T210 Produce Active and Inactive Receptor Forms: Correlations with Ligand Affinity, Receptor Stability, and Cellular Localization
Aaron M. D’Antona, Kwang H. Ahn, Debra A. Kendall · Biochemistry · 2006 · 58 citations · Full text
1–5 of 18